Observational study / 2016
Genetically elevated BMI was associated with an increased risk of multiple sclerosis.
Researchers conducted a two-sample Mendelian randomization study using summary statistics from the GIANT consortium (n = 322,105) and the IMSGC (14,498 cases and 24,091 controls) using 70 BMI-associated SNPs. A 1 standard deviation increase in genetically determined BMI was associated with a 41% increase in odds of multiple sclerosis (OR 1.41, 95% CI 1.20-1.66, p = 2.7 x 10^-5, I2 = 0%). Sensitivity analyses showed no evidence of pleiotropic effects, though the authors note that residual pleiotropy remains difficult to exclude entirely.
Shows an association, not proof of cause and effect.
- Study type
- Two-sample Mendelian randomization study
- Who was studied
- GIANT (n = 322,105) and IMSGC (14,498 MS cases and 24,091 controls)
- What was measured
- Risk of multiple sclerosis
THE PAPER
Obesity and Multiple Sclerosis: A Mendelian Randomization Study.
Mokry LE, Ross S, Timpson NJ, Sawcer S, Davey Smith G, Richards JB. PLoS Med, 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.